Published in J Mol Cell Cardiol on March 11, 2014
Cardiac gene therapy: are we there yet? Gene Ther (2016) 0.77
Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review. Heart Fail Rev (2016) 0.75
Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion. J Am Heart Assoc (2017) 0.75
Cardiac excitation-contraction coupling. Nature (2002) 18.48
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res (1999) 3.43
S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun (2004) 3.38
S100 proteins: structure, functions and pathology. Front Biosci (2002) 3.28
Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res (2003) 2.86
A review of the S100 proteins in cancer. Eur J Surg Oncol (2007) 2.64
Calcium cycling in congestive heart failure. J Mol Cell Cardiol (2002) 2.46
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation (2007) 1.73
Altered intracellular Ca2+ handling in heart failure. J Clin Invest (2005) 1.70
Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest (2004) 1.58
Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res (2006) 1.56
New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals (1998) 1.50
Reverse remodeling in heart failure--mechanisms and therapeutic opportunities. Nat Rev Cardiol (2011) 1.49
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
Molecular mechanisms of S100-target protein interactions. Microsc Res Tech (2003) 1.37
Adenovirus-mediated myofilament gene transfer into adult cardiac myocytes. Methods Cell Biol (1997) 1.37
Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. J Clin Invest (2010) 1.34
S100A6 - new facts and features. Biochem Biophys Res Commun (2009) 1.31
Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta (1996) 1.29
The multifunctional S100 protein family. Methods Mol Biol (2002) 1.24
Novel therapeutic approaches for heart failure by normalizing calcium cycling. Nat Rev Drug Discov (2004) 1.17
Ca2+ cycling and new therapeutic approaches for heart failure. Circulation (2010) 1.16
Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes. Circ Res (2007) 1.16
Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes. Mol Cell Biol (2007) 1.16
S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy. J Mol Cell Cardiol (2009) 1.13
Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes. J Cell Sci (2005) 1.06
Designing heart performance by gene transfer. Physiol Rev (2008) 1.03
S100 alpha, CAPL, and CACY: molecular cloning and expression analysis of three calcium-binding proteins from human heart. Biochemistry (1992) 1.01
The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes. Basic Res Cardiol (2002) 1.01
Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies. Biochem Biophys Res Commun (2007) 1.00
S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol (2005) 0.99
Calbindin and S100 protein expression in the developing inner ear in mice. J Comp Neurol (2009) 0.96
Isolation of a new member of the S100 protein family: amino acid sequence, tissue, and subcellular distribution. J Cell Biol (1989) 0.95
Stability of the contractile assembly and Ca2+-activated tension in adenovirus infected adult cardiac myocytes. Mol Cell Biochem (1998) 0.93
S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts. J Gene Med (2004) 0.91
Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling. Biophys J (2002) 0.90
S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function. J Biomed Biotechnol (2010) 0.89
Double oxygen-sensing vector system for robust hypoxia/ischemia-regulated gene induction in cardiac muscle in vitro and in vivo. Mol Ther (2008) 0.89
Genetic manipulation of calcium-handling proteins in cardiac myocytes. I. Experimental studies. Am J Physiol Heart Circ Physiol (2004) 0.89
S100A2 in cancerogenesis: a friend or a foe? Amino Acids (2010) 0.84
Crystal structure of Ca2+ -free S100A2 at 1.6-A resolution. J Mol Biol (2008) 0.83
Differential expression of S100 proteins in the developing human hippocampus and temporal cortex. Microsc Res Tech (2003) 0.80
Defective Ca2+ cycling as a key pathogenic mechanism of heart failure. Circ J (2008) 0.80
Targeting S100A1 in heart failure. Gene Ther (2012) 0.79
Regulation of Na+/Ca2+ exchange current in the normal and failing heart. Ann N Y Acad Sci (2007) 0.78
EC-coupling in normal and failing hearts. Scand Cardiovasc J (2005) 0.78
Sarcoplasmic reticulum and calcium cycling targeting by gene therapy. Gene Ther (2012) 0.78
The structure of Ca2+-loaded S100A2 at 1.3-Å resolution. FEBS J (2012) 0.76
Calcium mishandling in diastolic dysfunction: mechanisms and potential therapies. Biochim Biophys Acta (2012) 0.80